| Product Name: | Trimetazidine Dihydrochloride Modified Release Tablets |
| Brand Name: | Generic |
| Strength: | 20mg, 35mg |
| Dosage Form: | Tablets (Film-coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Antianginal |
| Indication: | Trimetazidine is a drug for angina pectoris (chest pain associated with blood flow to the heart). |
| Storage: | Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Trimetazidine Dihydrochloride Modified Release Tablets 20mg
- Trimetazidine Dihydrochloride Modified Release Tablets 35mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Trimetazidine Dihydrochloride Modified Release Tablets 20mg
Each Film-coated tablet contains:
Trimetazidine Dihydrochloride BP………….20mg
Excipients……………….q.s.
Colour: Lake of Erythrosine - Trimetazidine Dihydrochloride Modified Release Tablets 35mg
Each Film-coated tablet contains:
Trimetazidine Dihydrochloride BP………….35mg
Excipients……………….q.s.
Colour: Lake of Erythrosine
THERAPEUTIC INDICATIONS:
Trimetazidine is indicated for the symptomatic treatment of stable angina pectoris in patients inadequately controlled or intolerant to first line therapies.
CAUTION & WARNING:
CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Storage: Store at 20° to 25°C.
Dispense in tight container.
Dosage: As directed by the Physician